Conflict of interest The authors have no conflicts of interests to declare
Recently, it has been reported that an essential role in the pathogenesis of AD may be also played by other proteins such as -synuclein and the protein TDP-43 [7]
Custom-Tailored Treatment Protocols: Each patient receives an individualized treatment plan based on their insomnia typewhether idiopathic, comorbid (e.g., with anxiety or depression), or neurologicaland on the specific pathophysiology underlying their sleep disturbances
WHO data show that the incidence of type 2 diabetes has increased dramatically over the past few decades ( In recent years, an increasing number of drugs have been widely used in the clinic, including glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose co-transporter-2 inhibitors (SGLT-2is)
Comprising Delta Sleep-Inducing Peptide, DSIP Vials are intended for research purposes only
It is important to understand that products purchased from research chemical suppliers have no regulatory guarantees regarding purity, potency, or sterility
.png)
